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Multiple sclerosis (MS) is a chronic
autoimmune disease of the central nervous
system (CNS) that preferably affects young
adults and causes a multitude of symptoms
including visual disturbances, spasticity,
weakness, impairment of walking, coor-
dination difficulties, tremor/ataxia, sen-
sory problems, and bladder disturbances.
In addition, “invisible” symptoms such as
fatigue, depression, and cognitive dysfunc-
tion are also common and may even be
present early in the course of the dis-
ease (1). These symptoms often cause huge
disability and have an impact on fam-
ily, social, and work activities. Despite the
advances of pharmacological treatment,
particularly by disease-modifying thera-
pies, the majority of MS patients accumu-
late new lesions and disabilities along the
disease course and thus, there is a continu-
ing need for comprehensive, multidiscipli-
nary treatment, which constitutes the basic
concept of rehabilitation (2).
Rehabilitation is defined as a “problem-
solving educational process aimed at
reducing disability and handicap experi-
enced by someone as a result of disease
or injury” (3). The primary goal is to
reduce the limitations of activity and par-
ticipation in order to achieve the high-
est possible level of independence and to
increase and maintain quality of life of
MS patients (4). With respect to the large
variety of symptoms, a multidisciplinary
approach is required for MS rehabilitation
that includes physiotherapy, occupational
therapy, cognitive rehabilitation, psycho-
logical therapy, speech therapy, measures
for improving fatigue, and coping pro-
grams (2, 5). These measures facilitate
the reorganizing mechanisms within the
CNS and therefore, rehabilitation may be
regarded as “applied neuroplasticity.” This
article gives an overview of the most
recent scientific evidence and measures
of MS rehabilitation, and the relation-
ship between neuroplasticity and func-
tional improvement in MS.
MULTIDISCIPLINARY REHABILITATION
IN MS
There is a large interest in scientif-
ically sound studies dealing with the
effectiveness of neurorehabilitation. Dur-
ing the last decades, a growing body
of research has been performed, mainly
in stroke patients, but also in MS. A
recent update of a Cochrane review identi-
fied 10 randomized controlled trials deal-
ing with multidisciplinary rehabilitation
in MS (6). Although data are limited,
the available evidence suggests that inpa-
tient rehabilitation may have short-term
effects on activity and participation, but
not on impairment. Furthermore, there
was “moderate evidence” to support inpa-
tient or outpatient rehabilitation programs
to improve disability, bladder dysfunc-
tion, and participation that may last up
to 12 months. Since these effects dimin-
ish with time (7), repetition of multidis-
ciplinary rehabilitation seems necessary,
preferably on an annual base.
PHYSIOTHERAPY AND EXERCISE
THERAPY
Physiotherapy is one of the basic meth-
ods of MS rehabilitation and aims at
improving motor function, stability of
gait, and walking capabilities. More-
over, endurance and physical fitness may
also be strengthened and thus, fatigue
may be ameliorated. There are many
techniques and methodologies based on
neurophysiological concepts (i.e., Bobath,
Vojta, Brunkow, and proprioceptive neu-
romuscular stimulation) as well as newer
approaches such as equipment-supported
training, treadmill exercises, robot-assisted
gait training, and constraint-induced
movement therapy (CIMT) (2). Neither
of these techniques has shown superi-
ority about another which means that
the appropriate method should be cho-
sen according to the capabilities and dis-
abilities of the individual patient, but also
to the knowledge and resources of the
rehabilitation team. Physiotherapy may
also improve breathing dysfunction and
bladder disturbances by using training pro-
grams specifically directed toward respi-
ratory muscle and pelvic floor function,
respectively (2, 8).
In numerous studies, the beneficial
effects of exercise therapy for persons with
MS have been shown. Despite method-
ological problems (small sample sizes, het-
erogeneous groups of patients, different
interventions), there is good evidence that
exercise has positive effects on balance (9),
mobility (10), muscle weakness (11–13),
depression (14), and fatigue (15). There-
fore, persons with MS should be encour-
aged to participate regularly in endurance
and/or resistance training of low to mod-
erate intensity. These interventions are well
tolerated and not associated with side
effects (16, 17), but could positively influ-
ence both, the limitations caused by the
disease itself and the additionally decon-
ditioning effects of an inactive lifestyle.
COGNITIVE DYSFUNCTION AND
FATIGUE
Cognitive dysfunction often accompanies
the symptomatology of MS and is not
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necessarily associated with motor disabil-
ity. It may occur early in the disease
course and significantly affects employ-
ment, social life, and the activities of daily
living (18). The most commonly affected
areas are information processing speed,
attention, memory, visuo-constructive per-
formance, and executive functions (19). It
is of utmost importance to recognize these
problems as early as possible by appropriate
neuropsychological tests, and to tailor the
rehabilitation measures specifically toward
the cognitive deficit. Since drug treatment
is disappointing [the promising effects
of the anti-cholinesterase agent donepezil
could not be reproduced in a large random-
ized controlled trial (20)], treatment con-
sists of neuropsychological training, provi-
sion of aids, and supportive psychotherapy
[RIMS (21)]. Albeit with limited evidence,
a systematic review indicated that cognitive
training can improve memory span, work-
ing memory, and immediate visual mem-
ory (22). Moreover, benefits were found
for specific trainings of attention, execu-
tive functions, learning performance, and
memory (23, 24).
Fatigue is one of the most common and
debilitating symptoms in MS and clearly
different from normal tiredness. Patients
suffer from feelings of lassitude and abnor-
mal tiredness that may increase during the
day as well as lack of energy and moti-
vation, which all may impact activities of
daily living and work ability [RIMS (21)].
The pathogenesis is still unknown and
may involve different mechanisms such as
lesions of cortical and/or subcortical motor
pathways with involvement of motor cortex
and basal ganglia, decreased energy metab-
olism in the frontal cortex, autonomic dys-
function, endocrine disturbances, and dys-
regulation of the hypothalamus–pituitary–
adrenal axis [(25), RIMS (21)]. These
“primary” fatigue needs to be differenti-
ated from secondary mechanisms such as
sleep disorders, anemia, and thyroid dys-
function, but also from depression and
cognitive deficits. The subjective dimen-
sion of fatigue may be evaluated with
standardized questionnaires, and atten-
tion tests of alertness may be an objec-
tive assessment method (26). Drug treat-
ment is often not efficient. Therefore,
management of fatigue consists of non-
pharmacological measures such as counsel-
ing of patients and caregivers, structuring
the day with regular breaks, energy
management programs, cooling, specific
neuropsychological training (attention),
and exercise therapy (26).
NEUROREHABILITATION AS “APPLIED
NEUROPLASTICITY”
Within the last years, our knowledge about
the basic mechanisms that may be respon-
sible for the restoration of neurological
disabilities is rapidly increasing. It is now
generally accepted that even the mature
brain can undergo plastic changes (27).
Although the majority of studies are ded-
icated to the dynamic reorganization of
the motor system after an acute event, i.e.,
stroke (28), these neuroplastic changes may
also occur in a chronic disease as it is MS.
For instance, brain activation was exagger-
ated in MS patients with normal motor
function compared to healthy controls by
using a finger tapping paradigm (29). The
brain activation pattern changes with both,
increasing diffuse brain injury (assessed by
relative N -acetylaspartate concentration, a
marker of axonal integrity) and increas-
ing hand disability, and was present during
active as well as passive finger movements
reflecting true brain reorganization (30).
The same applies for cognitive function:
while MS patients in the early stages of
MS performed similarly to healthy controls
on clinical outcomes and the visual analog
of the Paced Auditory Serial Addition Test
(PASAT), brain activation was increased in
the patient group indicating that compen-
satory adaptive mechanisms (i.e., neuronal
plasticity) may be present very early in the
course of MS (31).
Zeller et al. tried to elucidate the basic
mechanisms underlying neuronal plastic-
ity in MS. For this purpose, rapid-onset
central motor plasticity was assessed in
22 patients with moderately severe, sta-
ble MS and compared to healthy controls
using paired associative stimulation (PAS),
a protocol that models long-term synaptic
potentiation in the cerebral cortex and that
combines repetitive electric nerve stimu-
lation with transcranial magnetic stimu-
lation (TMS). In contrast to the above
mentioned studies, MS patients performed
worse in clinical and paraclinical tests of
motor function, but the enhancement of
corticospinal excitability and the training-
induced increments of motor performance
were similar to controls. PAS-induced
plasticity and motor learning did not corre-
late with motor impairment or CNS injury.
Based upon their findings, the authors con-
cluded that the early steps of neuronal plas-
ticity are unlikely to limit the extent of
compensatory changes in MS and there-
fore, rehabilitation efforts should focus on
mechanisms supporting the later stages of
motor learning (32).
An intriguing question of current
research is whether rehabilitation proce-
dures may induce and/or support com-
pensatory adaptive changes. In this regard,
evidence albeit limited is available that
the clinical improvements of both, motor
and cognitive rehabilitation, correlate with
neural plasticity in the CNS of MS patients.
Sastre-Garriga et al. investigated 15 MS
patients and 5 healthy controls by func-
tional magnetic resonance imaging (fMRI)
with the PASAT paradigm. The cogni-
tive rehabilitation program consisted of
15 computer-supported sessions and 5
non-computer-supported cognitive stim-
ulation group sessions. After 5 weeks of
cognitive training, patients showed signif-
icant clinical improvement of their neu-
ropsychological performance, and this cor-
related to increased brain fMRI activ-
ity in several cerebellar areas (33). In a
double-blind, randomized controlled trial
of 12 MS patients, computer-assisted cog-
nitive rehabilitation of attention deficits
increased fMRI activity in the posterior
cerebellum and in the superior parietal lob-
ule in parallel to enhanced performance in
attention abilities compared with 11 age-
and gender-matched MS patients receiv-
ing a placebo intervention (34). Similarly,
visuomotor performance improved after
the first practice session of a visuomotor
task (short-term practice) and after 2 weeks
of daily sessions of the same task (longer-
term practice) in both, 23 MS patients
and 12 healthy controls. However, differ-
ent relationships between the improve-
ments of function and fMRI activity were
found between the groups: in MS patients,
increased function was associated with
lower activation in the sensorimotor, pos-
terior cingulate, and parahippocampal cor-
tices,whereas in controls,greater long-term
improvements correlated with smaller acti-
vation reductions in the visual cortex sup-
porting the notion that even in MS patients
with a high burden of pathology, brain
plasticity is preserved, and that cognitive
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systems different from those of healthy
controls contribute to this plasticity (35).
However, despite the promising results
that rehabilitation may indeed cause not
only clinical improvement of cognitive and
motor performance but also has distinct
effects on brain activation, the role of fMRI
in the context of clinical neurorehabilita-
tion needs to be elucidated.
When summarizing the above men-
tioned findings, there is little doubt that
plastic changes occur in the CNS, and that
these changes may be modulated by prac-
tice. From a clinical point of view, it is
obvious that patients undergoing neurore-
habilitation improve with practice. Thus,
these observations may bridge the gap
between basic science and clinical experi-
ence. The results from basic studies may
provide the scientific rationale to investi-
gate recovery-oriented strategies in clin-
ical trials and to implement them into
rehabilitation measures. Several promising
new rehabilitation techniques are exam-
ples of this approach: impairment-oriented
training, CIMT, electromyogram-triggered
neuromuscular stimulation, and robotic
interactive therapies (2). It should be kept
in mind that most of this evidence came
from studies in patients with stroke or
spinal cord injuries. However, more and
more studies support the usefulness of
these measures also in MS patients that
reflect the clinical experience that we have
made in our rehabilitation center during
the last years (5). High-quality, carefully
designed studies of the effectiveness of neu-
rorehabilitation are necessary that should
include both, clinical outcomes and neuro-
plastic measures. These studies may further
move MS rehabilitation from empirical
strategies toward evidence-based interven-
tions and help to elucidate the basic mech-
anisms that are responsible for the clini-
cal effects. Eventually, further research may
provide the base to develop effective thera-
pies that support the neuroplastic changes
responsible for functioning, activity, and
participation of persons with MS in order
to reach and maintain their optimal physi-
cal, sensory, intellectual, psychological, and
social functioning levels and promote the
best possible quality of life.
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